News for Acumen Pharmaceuticals, Inc. (ABOS)

PR NewswireSAN DIEGO, Feb. 26, 2025 SAN DIEGO, Feb. 26, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that D

PR NewswireSAN DIEGO, Feb. 18, 2025 Fourth Quarter Total Revenue Increased 30% YOY to $298 million and Royalty Revenue Increased 40% YOY to $170 millionFou

PR NewswireSAN DIEGO, Feb. 3, 2025 SAN DIEGO, Feb. 3, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that Janss

Acumen Pharmaceuticals CEO O'Connell sells shares worth $20,102

Acumen Pharmaceuticals COO Barton Russell sells shares worth $4,692

Acumen Pharmaceuticals chief legal officer sells shares worth $5,434

Phase 1 INTERCEPT-AD data published in Journal of Prevention of Alzheimer's Disease supports continued development of sabirnetug (ACU193) for treatment of early

Acumen Pharmaceuticals' chief legal officer sells $20,505 in stock

Acumen Pharmaceuticals COO Barton Russell sells $14,225 in stock

PR NewswireSAN DIEGO, Dec. 30, 2024 SAN DIEGO, Dec. 30, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that Tak

Halozyme Announces FDA Approval of Bristol Myers Squibb's Opdivo Qvantig™ with ENHANZE ® for Subcutaneous Use in Most Previously Approved Adult Solid Tumor Opdivo ® (nivolumab) Indications

PR NewswireSAN DIEGO, Nov. 27, 2024 SAN DIEGO, Nov. 27, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that m

HALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS

Stocks Analysis by Ismael De La Cruz covering: Blink Charging Co, Eledon Pharmaceuticals Inc, Nio Inc Class A ADR, Acumen Pharmaceuticals Inc. Read Ismael De La Cruz's latest article on Investing.com

Reiterating 2024 Financial Guidance: Total Revenue of $915-985 Million, Representing YOY Growth of 10-19%, Adjusted EBITDA of $535-585 Million, Representing YOY Growth of 26- 37% and Non-GAAP...

Balyasny Asset Management, a US-based hedge fund, has named Tarek Rizk as its head for the Mena market.

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.22%

Benzinga US Tech Embargo Has Pushed Beijing for Self-Sufficiency, Drives Local Chip Equipment Firms to Double Profits Chinese chip equipment makers Advanced Micro-Fabrication Equipment Inc and Naura Technology Group Co expect a doubling in profits after the U.S. tech embargo forced manufacturers to seek domestic alternatives. Advanced Micro-Fab said net income for the first half likely grew 110% - 120%. Naura reported on Friday a 121% - 156% growth in profit to as much as 1.93 billion yuan ($270

SEATTLE, June 28, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel...